HomeORGANIZATION
ORGANIZATION

Re-Pricing Rules Need Drastic Overhaul, Possible Abolishment Should Be Discussed for Z2: FPMAJ
(Jun.14.2016)

The Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ) issued a report on June 10, prodding the government to drastically overhaul re-pricing rules for big-selling drugs and review the so-called “Z2” price cut for off-patent brand-name drugs including an option ...
(LOG IN FOR FULL STORY)